BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17266085)

  • 1. Smoking and cognitive function in Parkinson's disease.
    Weisskopf MG; Grodstein F; Ascherio A
    Mov Disord; 2007 Apr; 22(5):660-5. PubMed ID: 17266085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women.
    Tworoger SS; Lee S; Schernhammer ES; Grodstein F
    Alzheimer Dis Assoc Disord; 2006; 20(1):41-8. PubMed ID: 16493235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease.
    De Reuck J; De Weweire M; Van Maele G; Santens P
    J Neurol Sci; 2005 Apr; 231(1-2):35-9. PubMed ID: 15792818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cigarette smoking and Parkinson's disease: a population based case-control study].
    Dong JQ; Zhang QH; Jiang ZX; Yi ZY; Yu L; Li ZH; Zhang YQ; Fang MJ; Zhang ZX; Zhang KL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):604-7. PubMed ID: 12975019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking in Parkinson's disease: influence on disease progression.
    Alves G; Kurz M; Lie SA; Larsen JP
    Mov Disord; 2004 Sep; 19(9):1087-1092. PubMed ID: 15372603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive dysfunction in Nigerians with Parkinson's disease.
    Akinyemi RO; Okubadejo NN; Akinyemi JO; Owolabi MO; Owolabi LF; Ogunniyi A
    Mov Disord; 2008 Jul; 23(10):1378-83. PubMed ID: 18546341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study.
    Janvin CC; Aarsland D; Larsen JP
    J Geriatr Psychiatry Neurol; 2005 Sep; 18(3):149-54. PubMed ID: 16100104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes preceding Parkinson's disease onset. A case-control study.
    D'Amelio M; Ragonese P; Callari G; Di Benedetto N; Palmeri B; Terruso V; Salemi G; Famoso G; Aridon P; Savettieri G
    Parkinsonism Relat Disord; 2009 Nov; 15(9):660-4. PubMed ID: 19356970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of dementia associated with Parkinson disease.
    Aarsland D; Kurz MW
    J Neurol Sci; 2010 Feb; 289(1-2):18-22. PubMed ID: 19733364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.
    Taylor CA; Saint-Hilaire MH; Cupples LA; Thomas CA; Burchard AE; Feldman RG; Myers RH
    Am J Med Genet; 1999 Dec; 88(6):742-9. PubMed ID: 10581500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and Parkinson's disease: a case-control study in a population characterized by a high prevalence of pesticide exposure.
    Galanaud JP; Elbaz A; Clavel J; Vidal JS; Corrèze JR; Alpérovitch A; Tzourio C
    Mov Disord; 2005 Feb; 20(2):181-9. PubMed ID: 15468111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-based case-control study of cigarette smoking and Parkinson disease.
    Scott WK; Zhang F; Stajich JM; Scott BL; Stacy MA; Vance JM
    Neurology; 2005 Feb; 64(3):442-7. PubMed ID: 15699372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multifactorial etiology of idiopathic Parkinson disease. A case-control study].
    Vieregge P; Friedrich HJ; Röhl A; Ulm G; Heberlein I
    Nervenarzt; 1994 Jun; 65(6):390-5. PubMed ID: 8072593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.